Aditxt
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aditxt and other ETFs, options, and stocks.About ADTX
Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore.
CEOAmro Albanna
CEOAmro Albanna
Employees26
Employees26
HeadquartersMountain View, California
HeadquartersMountain View, California
Founded2017
Founded2017
Employees26
Employees26
ADTX Key Statistics
Market cap953.85K
Market cap953.85K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume1.32M
Average volume1.32M
High today$2.73
High today$2.73
Low today$1.46
Low today$1.46
Open price$1.99
Open price$1.99
Volume39.99M
Volume39.99M
52 Week high$8,633.20
52 Week high$8,633.20
52 Week low$1.30
52 Week low$1.30
Stock Snapshot
The current Aditxt(ADTX) stock price is $1.47, with a market capitalization of 953.85K.
On 2025-12-17, Aditxt(ADTX) stock traded between a low of $1.46 and a high of $2.73. Shares are currently priced at $1.47, which is +0.7% above the low and -46.2% below the high.
The Aditxt(ADTX)'s current trading volume is 39.99M, compared to an average daily volume of 1.32M.
In the last year, Aditxt(ADTX) shares hit a 52-week high of $8,633.20 and a 52-week low of $1.30.
In the last year, Aditxt(ADTX) shares hit a 52-week high of $8,633.20 and a 52-week low of $1.30.
ADTX News
Benzinga 21h
What Sparked Aditxt Stock's 52% After‑Hours Surge?Aditxt Inc. (NASDAQ:ADTX) shares surged 52.11% in after-hours trading to $2.16 on Tuesday following the company’s filing of a definitive proxy statement for a s...
People also own
Based on the portfolios of people who own ADTX. This list is generated using Robinhood data, and it’s not a recommendation.